In some, but not all, individual experiments, we observed a significant platelet decrease 16 to 24 hours after infusion of 2A-2HC, before the administration of MWReg30 (see Additional File 2, Figure S2A).
In mice which had been primed with 50 mg kg-1 Cy 4 days before the administration of 300 mg kg-1 a growth delay of 32 days was achieved and 2/9 animals were alive at day 60.
Thirty minutes later, glucose (3 g/kg) was orally administered to each rat and blood samples were collected from the tail vein at −30 (just before the buspirone administration), 0 (just before the oral administration of glucose), 30, 60, 120, and 180 min after glucose load for the oral glucose tolerance test (OGTT).
In fact, the cell pretreatment with ICI 182,780 (i.e., 1 μM 30 min before E2 administration), the pure antagonist of both ERs, prevents the E2 effect on mitochondrial NGB cytochrome c association in the presence of H2O2.
We were unable to detect positive bands of Fas-L expression in the effusion cells before OK-432 administration.
The TCRV β gene analysis demonstrated a diverse expression of TCR genes in the effusion cells before OK-432 administration (pre-OK cells).
FDG PET/CT was performed at baseline (within 14 days prior to enrollment), at week 9 (before the third radium-223 administration), and at treatment discontinuation (week 17).
Blood samples were collected from the tail vein by tail milking at -30 just before the extract and glibenclamide administration), 0 (just before the oral administration of glucose), 30, 60, 90 and 120 min. after glucose load.
Blood samples were obtained from the jugular vein by direct puncture at time 0 (control just before the IV administration) and then 2, 15, 30, 60, 90 min.
The standard patient preparation before 124I administration has been described previously [14].
